OPKO Health Statistics
Total Valuation
OPKO Health has a market cap or net worth of $983.39 million. The enterprise value is $1.05 billion.
Important Dates
The last earnings date was Wednesday, April 30, 2025, after market close.
| Earnings Date | Apr 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OPKO Health has 793.05 million shares outstanding. The number of shares has decreased by -7.48% in one year.
| Current Share Class | 793.05M |
| Shares Outstanding | 793.05M |
| Shares Change (YoY) | -7.48% |
| Shares Change (QoQ) | -29.44% |
| Owned by Insiders (%) | 44.02% |
| Owned by Institutions (%) | 20.56% |
| Float | 375.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.23 |
| Forward PS | 1.44 |
| PB Ratio | 0.63 |
| P/TBV Ratio | 13.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.52 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.49, with a Debt / Equity ratio of 0.38.
| Current Ratio | 2.49 |
| Quick Ratio | 1.80 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.87 |
Financial Efficiency
Return on equity (ROE) is -3.04% and return on invested capital (ROIC) is -9.68%.
| Return on Equity (ROE) | -3.04% |
| Return on Assets (ROA) | -8.20% |
| Return on Invested Capital (ROIC) | -9.68% |
| Return on Capital Employed (ROCE) | -14.69% |
| Revenue Per Employee | $230,033 |
| Profits Per Employee | -$13,013 |
| Employee Count | 2,997 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 9.48 |
Taxes
In the past 12 months, OPKO Health has paid $38.42 million in taxes.
| Income Tax | 38.42M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.80% in the last 52 weeks. The beta is 1.42, so OPKO Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.42 |
| 52-Week Price Change | -0.80% |
| 50-Day Moving Average | 1.59 |
| 200-Day Moving Average | 1.55 |
| Relative Strength Index (RSI) | 28.20 |
| Average Volume (20 Days) | 3,252,398 |
Short Selling Information
The latest short interest is 34.89 million, so 4.40% of the outstanding shares have been sold short.
| Short Interest | 34.89M |
| Short Previous Month | 34.96M |
| Short % of Shares Out | 4.40% |
| Short % of Float | 9.30% |
| Short Ratio (days to cover) | 9.87 |
Income Statement
In the last 12 months, OPKO Health had revenue of $689.41 million and -$39.00 million in losses. Loss per share was -$0.06.
| Revenue | 689.41M |
| Gross Profit | 104.94M |
| Operating Income | -269.25M |
| Pretax Income | -244.67M |
| Net Income | -39.00M |
| EBITDA | -173.41M |
| EBIT | -269.25M |
| Loss Per Share | -$0.06 |
Full Income StatementBalance Sheet
The company has $428.83 million in cash and $492.89 million in debt, giving a net cash position of -$64.06 million or -$0.08 per share.
| Cash & Cash Equivalents | 428.83M |
| Total Debt | 492.89M |
| Net Cash | -64.06M |
| Net Cash Per Share | -$0.08 |
| Equity (Book Value) | 1.31B |
| Book Value Per Share | 1.95 |
| Working Capital | 441.75M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$182.48 million and capital expenditures -$23.76 million, giving a free cash flow of -$206.24 million.
| Operating Cash Flow | -182.48M |
| Capital Expenditures | -23.76M |
| Free Cash Flow | -206.24M |
| FCF Per Share | -$0.26 |
Full Cash Flow StatementMargins
Gross margin is 15.22%, with operating and profit margins of -39.06% and -5.66%.
| Gross Margin | 15.22% |
| Operating Margin | -39.06% |
| Pretax Margin | -0.08% |
| Profit Margin | -5.66% |
| EBITDA Margin | -25.15% |
| EBIT Margin | -39.06% |
| FCF Margin | n/a |
Dividends & Yields
OPKO Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 7.48% |
| Shareholder Yield | n/a |
| Earnings Yield | -3.97% |
| FCF Yield | -20.97% |
Dividend DetailsAnalyst Forecast
The average price target for OPKO Health is $2.75, which is 121.77% higher than the current price. The consensus rating is "Buy".
| Price Target | $2.75 |
| Price Target Difference | 121.77% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 7.04% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OPKO Health has an Altman Z-Score of -0.5 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.5 |
| Piotroski F-Score | 2 |